Centaurus Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Buy |
2,372
+61
| +3% | +$27.2K | 0.06% | 291 |
|
|
2025
Q1 | $1.12M | Buy |
2,311
+316
| +16% | +$153K | 0.07% | 261 |
|
|
2024
Q4 | $803K | Buy |
1,995
+137
| +7% | +$55.1K | 0.05% | 310 |
|
|
2024
Q3 | $864K | Buy |
1,858
+289
| +18% | +$134K | 0.06% | 290 |
|
|
2024
Q2 | $735K | Buy |
1,569
+136
| +9% | +$63.7K | 0.05% | 299 |
|
|
2024
Q1 | $599K | Buy |
1,433
+852
| +147% | +$356K | 0.04% | 351 |
|
|
2023
Q4 | $236K | Buy |
581
+116
| +25% | +$47.1K | 0.02% | 547 |
|
|
2023
Q3 | $162K | Buy |
465
+81
| +21% | +$28.2K | 0.01% | 617 |
|
|
2023
Q2 | $135K | Sell |
384
-71
| -16% | -$25K | 0.01% | 663 |
|
|
2023
Q1 | $143K | Buy |
455
+47
| +12% | +$14.8K | 0.01% | 756 |
|
|
2022
Q4 | $118K | Sell |
408
-48
| -11% | -$13.9K | 0.01% | 743 |
|
|
2022
Q3 | $132K | Buy |
456
+98
| +27% | +$28.4K | 0.01% | 729 |
|
|
2022
Q2 | $101K | Buy |
+358
| New | +$101K | 0.01% | 805 |
|
|
2021
Q2 | – | Sell |
-3,754
| Closed | -$807K | – | 932 |
|
|
2021
Q1 | $807K | Sell |
3,754
-756
| -17% | -$163K | 0.08% | 275 |
|
|
2020
Q4 | $1.07M | Buy |
4,510
+137
| +3% | +$32.4K | 0.11% | 216 |
|
|
2020
Q3 | $1.19M | Sell |
4,373
-53
| -1% | -$14.4K | 0.16% | 145 |
|
|
2020
Q2 | $1.29M | Buy |
4,426
+3,177
| +254% | +$922K | 0.19% | 139 |
|
|
2020
Q1 | $297K | Buy |
1,249
+21
| +2% | +$4.99K | 0.06% | 267 |
|
|
2019
Q4 | $269K | Buy |
+1,228
| New | +$269K | 0.04% | 395 |
|
|
2018
Q3 | – | Sell |
-235
| Closed | -$40K | – | 2002 |
|
|
2018
Q2 | $40K | Buy |
+235
| New | +$40K | 0.01% | 1032 |
|